This content is provided by Adam Golden.
Practice Areas
Head of the Corporate practice group in New York, Adam Golden advises life sciences companies on their most important transactions. Clients turn to Adam for his dual skillset, which combines his strengths as a mergers and acquisitions and corporate lawyer, with those of an intellectual property transactions lawyer. This enables him to represent pharmaceutical, biotechnology, and medical device companies in the full scope of transactions that are common to this sector.
Career
J.D., New York University School of Law, 1990; A.B., Princeton University, 1986
Articles, Highlights and Press Releases
Total 1 Articles, Highlights and Press Releases
Hogan Lovells advises Shire in ex-U.S. closing of its US$2.4bn business sale to Servier S.A.S.
Marek Wroniak, Mahvesh Qureshi, Mikael Salmela, Tom Brassington, Birgit Reese, Adam Golden, Tomasz Zak, Alex Dolmans, Xavier Doumen, Arne Thiermann
Read now